We only have this paper's title and publication details.
Read it at the sourceFD-OCT is safe in an unselected and heterogeneous group of patients with varying clinical settings.
No takes yet. Share an insight, caveat, or question.
Sijde et al. (2016) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: